Article Versions Notes

Si Y, Guan J, Xu Y, Chen K, Kim S, Zhou L, Jaskula-Sztul R, Liu XM. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics. 2020; 12(11):1079. https://doi.org/10.3390/pharmaceutics12111079

Si, Yingnan, JiaShiung Guan, Yuanxin Xu, Kai Chen, Seulhee Kim, Lufang Zhou, Renata Jaskula-Sztul, and X. Margaret Liu. 2020. "Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment" Pharmaceutics 12, no. 11: 1079. https://doi.org/10.3390/pharmaceutics12111079

Si, Y., Guan, J., Xu, Y., Chen, K., Kim, S., Zhou, L., Jaskula-Sztul, R., & Liu, X. M. (2020). Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics, 12(11), 1079. https://doi.org/10.3390/pharmaceutics12111079